PGP and non-small cell lung carcinoma: The present study demonstrated that elevated HDAC activity and increased P-gp expression in NSCLC may induce resistance to treatment with cisplatin, indicating that both proteins, especially HDAC, may be useful indicators of cisplatin resistance in NSCLC.